Filter your results：

• 1.Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys

  Impact Factor：5.7

  Published：EBioMedicine

• 2.Saccharomyces cerevisiae fermentation products reduce bacterial endotoxin concentrations and inflammation during grain-based subacute ruminal acidosis …

  Impact Factor：4

  Published：J Dairy Sci

• 3.Comparative studies on the effect of pig adipose-derived stem cells (pASCs) preconditioned with hypoxia or normoxia on skin wound healing in mice

  Impact Factor：3.9

  Published：Experimental Cell Research

• 4.Structural and signaling mechanisms of TAAR1 enabled preferential agonist design

  Impact Factor：64.5

  Published：Cell

• 5.Melatonin and its bioisosteres as potential therapeutic agents for the treatment of retinopathy of prematurity

  Impact Factor：3

  Published：Chemical Biology & Drug Design

• 6.Oleuropein Has Modulatory Effects on Systemic Lipopolysaccharide-Induced Neuroinflammation in Male Rats

  Impact Factor：4.2

  Published：J Nutr

• 7.Extracellular Vesicles of the Probiotic Escherichia coli Nissle 1917 Reduce PepT1 Levels in IL-1β-Treated Caco-2 Cells via Upregulation of miR-193a-3p

  Impact Factor：4.8

  Published：Nutrients

• 8.The Role of Hydrogen Sulfide in the Localization and Expression of p53 and Cell Death in the Nervous Tissue in Traumatic Brain Injury and Axotomy

  Impact Factor：4.9

  Published：Int J Mol Sci

• 9.Melatonin Plays a Protective Role by Regulating miR-26a-5p-NRSF and JAK2-STAT3 Pathway to Improve Autophagy, Inflammation and Oxidative Stress of …

  Impact Factor：3.2

  Published：Drug Design Development and Therapy

• 10.Anti-amnesic and neuroprotective effects of Fluoroethylnormemantine (FENM) in a pharmacological mouse model of Alzheimer's disease

  Impact Factor：5.7

  Published：International Journal of Neuropsychopharmacology

• 11.H2S prevents the disruption of the blood-brain barrier in rats with prenatal hyperhomocysteinemia

  Impact Factor：3.5

  Published：J Pharmacol Sci

• 12.The selective butyrylcholinesterase inhibitor UW‐MD‐95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's …

  Impact Factor：4.8

  Published：CNS Neuroscience & Therapeutics

• 13.Linagliptin, a DPP‐4 inhibitor, activates AMPK/FOXO3a and suppresses NFκB to mitigate the debilitating effects of diethylnitrosamine exposure in rat liver: Novel …

  Impact Factor：4.8

  Published：FASEB Journal

• 14.The correlation of the peripheral blood NT-proBNP and NF-κB expression levels with the myocardial infarct area and the post-treatment no-reflow in acute …

  Impact Factor：3.9

  Published：Am J Transl Res